OpGen to Present at the Rodman & Renshaw 18th Annual Global Investment Conference
September 07 2016 - 6:30AM
OpGen, Inc. (NASDAQ:OPGN) an informatics and
genomic analysis company, announces that Evan Jones, the Company’s
Chairman and Chief Executive Officer, will provide a corporate
update at the Rodman & Renshaw 18th Annual Global Investment
Conference. Mr. Jones’ presentation will be on Monday,
September 12, 2016 at 3:25 p.m. Eastern time. The conference is
being held from September 11 to 13 in New York City.
To listen to the presentation live, investors may visit the
investor relations section of OpGen, Inc.’s website at
www.opgen.com. An archived audio of the presentation will also be
available on OpGen’s website for 90 days.
About OpGen
OpGen, Inc. is harnessing the power of informatics and genomic
analysis to provide complete solutions for patient, hospital and
network-wide infection prevention and treatment. Learn more at
www.opgen.com and follow OpGen on Twitter and LinkedIn.
Contacts:
OpGenMichael FarmerDirector, Marketing(240)
813-1284
mfarmer@opgen.com InvestorRelations@opgen.com
Investor RelationsLHAKim Sutton Golodetz(212)
838-3777kgolodetz@lhai.comBruce Voss(310)
691-7100bvoss@lhai.com
OpGen Media MacDougall Biomedical
Communications Cammy Duong(781) 235-3060cduong@macbiocom.com
OpGen (NASDAQ:OPGN)
Historical Stock Chart
From Aug 2024 to Sep 2024
OpGen (NASDAQ:OPGN)
Historical Stock Chart
From Sep 2023 to Sep 2024